Gilead Sciences, Inc. (NASDAQ: GILD) announced that the company’s Board of Directors has declared a cash dividend of $0.43 per share of common stock for the third quarter of 2015. The dividend is payable on September 29, 2015, to stockholders of record at the close of business on September 16, 2015. Future dividends will be subject to Board approval. Gilead Sciences Inc. (NASDAQ:GILD) belongs to Healthcare sector. Its net profit margin is 51.50% and weekly performance is -2.21%. On last trading day company shares ended up $115.30. Gilead Sciences Inc. (NASDAQ:GILD) distance from 50-day simple moving average (SMA50) is -1.04%.
Opko Health, Inc. (NYSE:OPK) reported Net loss for the three and six months ended June 30, 2015 was $42.8 million and $159.9 million and included increased operating expenses including increased research and development expense of $13.3 million and $17.8 million, respectively, in comparison to the 2014 periods. Consolidated revenues increased to $42.4 and $72.5 million during the three and six months ended June 30, 2015 from $23.5 and $45.8 million in the comparable periods of 2014. Revenue for the three and six months ended June 30, 2015 included $17.7 and $30.2 million of revenue resulting from OPKO’s collaboration agreement with Pfizer. Opko Health, Inc. (NYSE:OPK) shares decreased -13.72% in last trading session and ended the day at $13.90. OPK Gross Margin is 53.60% and its return on assets is -18.10%. Opko Health, Inc. (NYSE:OPK) quarterly performance is -1.70%.
Aimmune Therapeutics, Inc. (NASDAQ: AIMT) announced the pricing of its initial public offering of 10,000,000 shares of its common stock at a public offering price of $16.00 per share, before underwriting discounts and commissions. In addition, Aimmune has granted the underwriters a 30-day option to purchase up to an additional 1,499,999 shares of common stock at the same price. On 06 August, Aimmune Therapeutics, Inc. (NASDAQ:AIMT) shares increased 50.63% and was closed at $24.10.
Exelixis, Inc. (NASDAQ:EXEL) announced that its second quarter 2015 financial results will be released on Tuesday, August 11, 2015 after the markets close. At 5:00 p.m. EDT / 2:00 p.m. PDT, Exelixis management will host a conference call to discuss the results and provide a general business update. Exelixis, Inc. (NASDAQ:EXEL) ended the last trading day at $5.89. Company weekly volatility is calculated as 9.28% and price to cash ratio as 11.48. Exelixis, Inc. (NASDAQ:EXEL) showed a weekly performance of 6.32%.